摘要
115例确诊为桥本甲状腺炎的患者,其中59例予以亚硒酸钠和左旋甲状腺素(L-T4)治疗,其余患者仍以L-T4治疗,随访3个月后,结果显示硒治疗组中56%患者甲状腺过氧化物酶抗体降低,61%患者甲状腺球蛋白抗体降低,此结果优于单纯L-T4治疗组。
A total of 115 patients with Hoshimoto thyroiditis were classified under 2 groups: one group being treated with selenium and L-throxine (L-T4) and other group with L-T4 alone. All patients were followed up for 3 months. In the selenium treated group thyroid peroxidase antibody level was decreased in 33 patients (56%) and thyroglobulin antibody level was decreased in 36 patients ( 61% ), which seems to be superior to those in solely L-T4 treated cases.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2008年第2期194-195,共2页
Chinese Journal of Endocrinology and Metabolism